1. Auerbach, Scott S, Dekeyser, Joshua G, Stoner, Matthew A, Omiecinski, Curtis J. 2006. CAR2 displays unique ligand binding and RXRalpha heterodimerization characteristics. In Drug metabolism and disposition: the biological fate of chemicals, 35, 428-39. doi:. https://pubmed.ncbi.nlm.nih.gov/17194715/
2. Saxe, C L, Ginsburg, G T, Louis, J M, Devreotes, P N, Kimmel, A R. . CAR2, a prestalk cAMP receptor required for normal tip formation and late development of Dictyostelium discoideum. In Genes & development, 7, 262-72. doi:. https://pubmed.ncbi.nlm.nih.gov/8436297/
3. Li, Junping, Hu, Hong, Lian, Hui, Yang, Lili, Zhang, Zhenfeng. 2024. NK-92MI Cells Engineered with Anti-claudin-6 Chimeric Antigen Receptors in Immunotherapy for Ovarian Cancer. In International journal of biological sciences, 20, 1578-1601. doi:10.7150/ijbs.88539. https://pubmed.ncbi.nlm.nih.gov/38481806/
4. Park, H D, Scott, S, Rai, R, Dorrington, R, Cooper, T G. . Synergistic operation of the CAR2 (Ornithine transaminase) promoter elements in Saccharomyces cerevisiae. In Journal of bacteriology, 181, 7052-64. doi:. https://pubmed.ncbi.nlm.nih.gov/10559172/
5. Tran, Tri Minh, Chand Thakuri, Bal Krishna, Nurmukhambetova, Saule, Dash, Pradyot, Schneider, Dina. 2024. Armored TGFβRIIDN ROR1-CAR T cells reject solid tumors and resist suppression by constitutively-expressed and treatment-induced TGFβ1. In Journal for immunotherapy of cancer, 12, . doi:10.1136/jitc-2023-008261. https://pubmed.ncbi.nlm.nih.gov/38609317/
6. Jiang, Jiaxuan, Kong, Kangjie, Fang, Xiuli, Yu-Wai-Man, Patrick, Zhang, Xiulan. 2024. CRISPR-Cas9-mediated deletion of carbonic anhydrase 2 in the ciliary body to treat glaucoma. In Cell reports. Medicine, 5, 101524. doi:10.1016/j.xcrm.2024.101524. https://pubmed.ncbi.nlm.nih.gov/38670096/
智鼠故事 
